Abstract
Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis (P5-3.010)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have